Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 271

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel

Open access
Pilishvili, Tamara, Gierke, Ryan, Fleming-Dutra, Katherine E., Farrar, Jennifer L., Mohr, Nicholas M., Talan, David A., Krishnadasan, Anusha, Harland, Karisa K., Smithline, Howard A., Hou, Peter C., Lee, Lilly C., Lim, Stephen C., Moran, Gregory J., Krebs, Elizabeth, Steele, Mark T., Beiser, David G., Faine, Brett, Haran, John P., Nandi, Utsav, Schrading, Walter A., Chinnock, Brian, Henning, Daniel J., Lovecchio, Frank, Lee, Jane, Barter, Devra, Brackney, Monica, Fridkin, Scott K., Marceaux-Galli, Kaytlynn, Lim, Sarah, Phipps, Erin C., Dumyati, Ghinwa, Pierce, Rebecca, Markus, Tiffanie M., Anderson, Deverick J., Debes, Amanda K., Lin, Michael Y., Mayer, Jeanmarie, Kwon, Jennie H., Safdar, Nasia, Fischer, Marc, Singleton, Rosalyn, Chea, Nora, Magill, Shelley S., Verani, Jennifer R., Schrag, Stephanie J.·2021·New England Journal of Medicine

Abstract

BACKGROUND: The prioritization of U.S. health care personnel for early receipt of messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), allowed for the evaluation of the effectiveness of these new vaccines in a real-world setting. METHODS: We conducted a test-negative case-control study involving health care personnel across 25 U.S. states. Cases were defined on the basis of a positive polymerase-chain-reaction (PCR) or antigen-based test for SARS-CoV-2 and at least one Covid-19-like symptom. Controls were defined on the basis of a negative PCR test for SARS-CoV-2, regardless of symptoms, and were matched to cases according to the week of the test date and site. Using conditional logistic regression with adjustment for age, race and ethnic group, underlying conditions, and exposures to persons with Covid-19, we estimated vaccine effectiveness for partial vaccination (assessed 14 days after receipt of the first dose through 6 days after receipt of the second dose) and complete vaccination (assessed ≥7 days after receipt of the second dose). RESULTS: The study included 1482 case participants and 3449 control participants. Vaccine effectiveness for partial vaccination was 77.6% (95% confidence interval [CI], 70.9 to 82.7) with the BNT162b2 vaccine (Pfizer-BioNTech) and 88.9% (95% CI, 78.7 to 94.2) with the mRNA-1273 vaccine (Moderna); for complete vaccination, vaccine effectiveness was 88.8% (95% CI, 84.6 to 91.8) and 96.3% (95% CI, 91.3 to 98.4), respectively. Vaccine effectiveness was similar in subgroups defined according to age (<50 years or ≥50 years), race and ethnic group, presence of underlying conditions, and level of patient contact. Estimates of vaccine effectiveness were lower during weeks 9 through 14 than during weeks 3 through 8 after receipt of the second dose, but confidence intervals overlapped widely. CONCLUSIONS: The BNT162b2 and mRNA-1273 vaccines were highly effective under real-world conditions in preventing symptomatic Covid-19 in health care personnel, including those at risk for severe Covid-19 and those in racial and ethnic groups that have been disproportionately affected by the pandemic. (Funded by the Centers for Disease Control and Prevention.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2106599

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 271

Metadata

Authors
Pilishvili, T., Gierke, R., Fleming-Dutra, K. E., Farrar, J. L., Mohr, N. M., Talan, D. A., Krishnadasan, A., Harland, K. K., Smithline, H. A., Hou, P. C., Lee, L. C., Lim, S. C., Moran, G. J., Krebs, E., Steele, M. T., Beiser, D. G., Faine, B., Haran, J. P., Nandi, U., Schrading, W. A., Chinnock, B., Henning, D. J., Lovecchio, F., Lee, J., Barter, D., Brackney, M., Fridkin, S. K., Marceaux-Galli, K., Lim, S., Phipps, E. C., Dumyati, G., Pierce, R., Markus, T. M., Anderson, D. J., Debes, A. K., Lin, M. Y., Mayer, J., Kwon, J. H., Safdar, N., Fischer, M., Singleton, R., Chea, N., Magill, S. S., Verani, J. R., & Schrag, S. J.
Venue
New England Journal of Medicine
Published
2021-12-16
Volume
385
Issue
25
Pages
e90-e90
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W3199320310
Cited by
271
References
22
FWCI
17.92
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel. https://app.cochat.ai/papers/10.1056/nejmoa2106599
The paper
Pilishvili, T., Gierke, R., Fleming-Dutra, K. E., Farrar, J. L., Mohr, N. M., Talan, D. A., Krishnadasan, A., Harland, K. K., Smithline, H. A., Hou, P. C., Lee, L. C., Lim, S. C., Moran, G. J., Krebs, E., Steele, M. T., Beiser, D. G., Faine, B., Haran, J. P., Nandi, U., . . . Schrag, S. J. (2021). Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2106599

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.